标普和纳斯达克内在价值 联系我们

SeaSpine Holdings Corporation SPNE NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.38
-1.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

SeaSpine Holdings Corporation (SPNE) .

本页证实的标准:

  • VALUE (35/100, 未通过) — 综合估值评分低于60/100的通过门槛。
  • 分析师共识目标价 $9.38 (-1.7% 下行风险) — 轻微下行风险 — 市场可能已超前于分析师预期。

SharesGrow 综合评分: 41/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
41/100
SG Score
View full scorecard →
价值
35/100
Price-to-Earnings & upside
Proven by this page
未來
74/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
~
护城河
54/100
→ Income
~
成长
48/100
→ Income
收入
10/100
→ Income

估值概览 — SPNE

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率1.67
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.62
每股账面价值$0.00
每股营收$5.70
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$9.38 (-1.7%)

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2012 $-2.78 $147.51M $-30.42M -20.6%
2013 $-2.35 $146.59M $-25.75M -17.6%
2014 $-2.24 $138.7M $-24.55M -17.7%
2015 $-4.99 $133.18M $-55.53M -41.7%
2016 $-3.85 $128.86M $-43.21M -33.5%
2017 $-2.58 $131.81M $-32.12M -24.4%
2018 $-2.18 $143.44M $-33.52M -23.4%
2019 $-2.07 $159.08M $-39.28M -24.7%
2020 $-1.59 $154.35M $-43.18M -28%
2021 $-1.62 $191.45M $-54.35M -28.4%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言